Fig. 3.
Fig. 3. Stable long-term transgene expression in all peripheral donor white blood cell types with preferential representation of NGFR+ cells in Gr-1+ and Mac-1+donor WBCs. / NGFR expression was analyzed by flow cytometry as in Figure 1. Data represented the mean percentage ± SEM of NGFR+ cells in peripheral blood of 7 mice from experiment 2 at various time-points after transplantation of bone marrow cells transduced with the 1171 vector. There were no significant declines (P < .05) in the percentage of NGFR+ cells within a given phenotypic cell population sampled after the second month after transplantation. Note that the frequency of NGFR+ cells was consistently greater in Ly5.2+Gr-1+ or Ly5.2+Mac-1+ myeloid cells than in all other cell types at each time-point. For Gr-1+ versus B220+, CD3e+, RBCs, or platelets,P < .001 (n = 7) at days 116 and 161, andP < 0.03 (n = 3) at day 249. For Mac-1+versus B220+, CD3e+, RBCs, or platelets,P < .009 (n = 7) at days 116 and 161, andP < .02 (n = 3) at day 249, except for Mac-1+versus B220+. All abbreviations are as in Figures 1 and2.

Stable long-term transgene expression in all peripheral donor white blood cell types with preferential representation of NGFR+ cells in Gr-1+ and Mac-1+donor WBCs.

NGFR expression was analyzed by flow cytometry as in Figure 1. Data represented the mean percentage ± SEM of NGFR+ cells in peripheral blood of 7 mice from experiment 2 at various time-points after transplantation of bone marrow cells transduced with the 1171 vector. There were no significant declines (P < .05) in the percentage of NGFR+ cells within a given phenotypic cell population sampled after the second month after transplantation. Note that the frequency of NGFR+ cells was consistently greater in Ly5.2+Gr-1+ or Ly5.2+Mac-1+ myeloid cells than in all other cell types at each time-point. For Gr-1+ versus B220+, CD3e+, RBCs, or platelets,P < .001 (n = 7) at days 116 and 161, andP < 0.03 (n = 3) at day 249. For Mac-1+versus B220+, CD3e+, RBCs, or platelets,P < .009 (n = 7) at days 116 and 161, andP < .02 (n = 3) at day 249, except for Mac-1+versus B220+. All abbreviations are as in Figures 1 and2.

Close Modal

or Create an Account

Close Modal
Close Modal